7月4日盘中，港股上市公司华昊中天医药-B（02563）股价大幅飙升，涨幅高达33.59%，引发市场广泛关注。该股此轮强势上涨，主要得益于中国政府近期出台的创新药支持政策。
消息面上，7月1日国家医保局、国家卫健委联合发布《支持创新药高质量发展的若干措施》，为创新药企业发展提供了政策支持。这一利好消息推动港股创新药概念股集体走强，其中华昊中天医药表现尤为突出。
中信证券分析认为，随着我国创新药发展取得阶段性成效，新政策将进一步完善对创新药高质量发展的支持。该券商建议投资者关注创新驱动、国际化、自主可控以及院外营销模式改革等领域，预计医药板块将迎来稳步上涨。在此背景下，华昊中天医药-B的股价大涨或反映了投资者对公司未来发展前景的乐观预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.